Artimino 2015

Conference on Medical Ultrasound

The conference took place 7-10 June, 2015 at the Örenäs castle close to Helsinborg, Sweden.
The 2015 Artimino Ultrasound Conference was the 17th in a series of semi-annual conferences (begun as the New England Doppler Conferences) on the physics, bioengineering and clinical applications of ultrasound.

The New England Doppler Conference series was founded more than 30 years ago with the intention of giving scientists, engineers and clinicians an opportunity to discuss in depth the technical challenges of diagnosis using ultrasound in a remote, but comfortable setting and with a limited number of people. The format has been one of structured discussions rather than formal proffered papers.

Many major developments in the field, including the duplex scanner, colour Doppler imaging, vector velocity imaging, quantitative methods of haemodynamic assessment, nonlinear imaging as well as numerous technical and clinical innovations have been pioneered by participants of the New England Doppler and Artimino Conferences and discussed at its meetings.

For this 17th conference, the discussion focused on leading edge developments such as microbubble and nanodroplet contrast agents, vector velocity, nonlinear and high frequency imaging as well as new developments in photoacoustics, ultrafast acquisition and synthetic aperture techniques. As a forum for discussion, the conference has traditionally paid special attention to its graduate student participants, a limited number of whom were invited to attend at a subsidised rate.

Conference objectives were:

  • To provide a forum to assess the current state-of-the-art ultrasound imaging and its applications in noninvasive diagnosis and therapy
  • To identify key problems needing solutions for practical deployment
  • To share insights into future directions with experts in allied imaging methodologies such as MRI and optics

The conference provided a unique opportunity to address in depth a diverse range of key topics in ultrasound imaging and therapy, including:

  • Ultrasound elastography
  • Microbubble and nanodroplet contrast agents
  • High frequency imaging and vector velocity imaging
  • Photoacoustic imaging
  • Gene and drug delivery with ultrasound
  • Angiogenesis and tumour vascular imaging
  • Quantitative haemodynamic measurement
  • Cardiac and myocardial perfusion imaging
  • Nonlinear imaging methods
  • 3-D/4-D anatomic and flow imaging
  • Ultrafast and synthetic aperture anatomic and flow imaging

For further information, contact:

Jørgen Arendt Jensen

Magnus Cinthio

Tomas Jansson
20 OCTOBER 2020